Section Arrow
Quote
IPA.NASDAQ
- ImmunoPrecise Antibodies Ltd
(Financial Status)
Quotes are at least 15-min delayed:2025/06/02 09:12 EDT
Last
 --
-- (--)
Day High 
-- 
Prev. Close
0.57 
1-M High
0.579999 
Volume 
-- 
Bid
0.562
Ask
0.566
Day Low
-- 
Open
-- 
1-M Low
0.4294 
Market Cap 
26.09M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.52 
20-SMA 0.5 
50-SMA 0.45 
52-W High 1.14 
52-W Low 0.27 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.68/0.02
Enterprise Value
38.20M
Balance Sheet
Book Value Per Share
0.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
19.36M
Operating Revenue Per Share
0.36
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ZYMEZymeworks----0.000%-- 
ZVSAZyVersa Therapeutics----0.000%0PE
ZVRAZevra Therapeutics----0.000%-- 
ZURAZura Bio Limited----0.000%5.54PE
ZNTLZentalis Pharmaceuticals----0.000%-- 
Quotes are at least 15-min delayed：2025/06/02 09:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.